Monsanto Company (MON) : Smith Moore reduced its stake in Monsanto Company by 24.4% during the most recent quarter end. The investment management company now holds a total of 8,683 shares of Monsanto Company which is valued at $913,886 after selling 2,802 shares in Monsanto Company , the firm said in a disclosure report filed with the SEC on Aug 10, 2016.Monsanto Company makes up approximately 0.36% of Smith Moore’s portfolio.
Other Hedge Funds, Including , Sentry Investment Management boosted its stake in MON in the latest quarter, The investment management firm added 1,664 additional shares and now holds a total of 34,829 shares of Monsanto Company which is valued at $3,665,752. Monsanto Company makes up approx 0.15% of Sentry Investment Management’s portfolio.Riverpark Advisors reduced its stake in MON by selling 3,832 shares or 17.75% in the most recent quarter. The Hedge Fund company now holds 17,755 shares of MON which is valued at $1,852,912. Monsanto Company makes up approx 0.85% of Riverpark Advisors’s portfolio.Zurcher Kantonalbank (zurich Cantonalbank) reduced its stake in MON by selling 76,074 shares or 46.25% in the most recent quarter. The Hedge Fund company now holds 88,407 shares of MON which is valued at $9,226,155. Monsanto Company makes up approx 0.12% of Zurcher Kantonalbank (zurich Cantonalbank)’s portfolio.Ftb Advisors reduced its stake in MON by selling 536 shares or 41.74% in the most recent quarter. The Hedge Fund company now holds 748 shares of MON which is valued at $79,864. Monsanto Company makes up approx 0.01% of Ftb Advisors’s portfolio.Strs Ohio reduced its stake in MON by selling 105 shares or 0.04% in the most recent quarter. The Hedge Fund company now holds 273,253 shares of MON which is valued at $29,169,758. Monsanto Company makes up approx 0.13% of Strs Ohio’s portfolio.
Monsanto Company opened for trading at $103.7 and hit $104.83 on the upside on Friday, eventually ending the session at $104.15, with a gain of 0.15% or 0.16 points. The heightened volatility saw the trading volume jump to 21,19,785 shares. Company has a market cap of $45,573 M.
On the company’s financial health, Monsanto Company reported $2.17 EPS for the quarter, missing the analyst consensus estimate by $ -0.23 based on the information available during the earnings call on Jun 29, 2016. Analyst had a consensus of $2.40. The company had revenue of $4189.00 million for the quarter, compared to analysts expectations of $4487.57 million. The company’s revenue was down -8.5 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $2.39 EPS.
Many Wall Street Analysts have commented on Monsanto Company. Monness Crespi & Hardt Upgraded Monsanto Company on Aug 8, 2016 to ” Buy”, Price Target of the shares are set at $130.Monsanto Company was Upgraded by Jefferies to ” Buy” on May 25, 2016.
Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds biotechnology trait products and herbicides provide farmers with solutions that improve productivity reduce the costs of farming and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics and Agricultural Productivity. Through its Seeds and Genomics segment it produces seed brands including DEKALB Asgrow Deltapine Seminis and De Ruiter and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.